Ask AI
Improving Outcomes in Pediatric Patients with AD

CE / CME

From Flare to Control in Atopic Dermatitis: Improving Outcomes in Pediatric Patients With Moderate to Severe Disease

Nurse Practitioners/Nurses: 1.00 Nursing contact hours, includes 1.00 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Released: June 27, 2025

Expiration: June 26, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

A 7-year-old girl presents with moderate to severe atopic dermatitis (AD) that has been poorly controlled with emollients and low-potency topical corticosteroids. She has significant pruritus, sleep disturbance, and frequent flares, which have affected her school performance and emotional well-being. Her parents report feeling overwhelmed by the time-consuming treatment regimen. Which of the following would be the most appropriate next step in managing this patient’s AD?

2.

A 10-yr-old boy with moderate to severe AD has experienced inadequate symptom control with high-potency topical corticosteroids and topical calcineurin inhibitors. He continues to have significant pruritus, sleep disruption, and poor quality of life. You are considering starting a biologic therapy. Based on the current evidence, which of the following biologic therapies is the most appropriate for this patient?

3.

A 9-year-old girl with moderate to severe AD presents with persistent pruritus, skin lesions, and difficulty sleeping despite using topical corticosteroids and emollients. You are considering initiating a systemic biologic therapy. To incorporate shared decision-making (SDM) into the treatment plan, which of the following would be the most effective approach?

4.

How confident are you in treating your pediatric patients with atopic dermatitis?